MedPath

The Impact of Fish Oil Supplementation on The Efficacy and Side Effects of Low-dose Isotretinoin in Treatment of Moderate-to-severe Acne Vulgaris Compared to Low-dose Isotretinoin Monotherapy.

Phase 3
Recruiting
Conditions
male or female patients aged 18-25 years with moderate to severe acne vulgaris
acne, isotretinoin, fish oil, mucocutaneous side effects
Registration Number
TCTR20240810002
Lead Sponsor
Ratchadapiseksompotch Fund Chulalongkorn university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

1. male or female, aged 18-25 years, diagnosed with moderate to severe acne vulgaris 2. BMI < 29.9 3. ability to follow research protocols

Exclusion Criteria

1. Individuals with a history of used topical treatment for acne vulgaris within a past month 2. Those who have documented allergy to isotretinoin 3. individuals with a history of taking fish oil supplements within the past 3 months 4. Those who have undergone procedures or treatments for acne with any options 5. individuals with diseases associated with acne, such as PCOS 6. on current medication that impacts acne, such as corticosteroids, JAK inhibitors 7. individuals with dyslipidemia, liver disease 8. bleeding tendency 9. pregnant or breastfeeding women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
impact of fish oil on efficacy of isotretinoin in acne improvement. baseline, 1 month, 2 months, 3 months the outcome was based on the investigator global assessment (IGA) score and the lesion counts (both inflammatory and non-inflammatory) on the entire face.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath